264 related articles for article (PubMed ID: 29535300)
1. Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.
Danussi C; Bose P; Parthasarathy PT; Silberman PC; Van Arnam JS; Vitucci M; Tang OY; Heguy A; Wang Y; Chan TA; Riggins GJ; Sulman EP; Lang FF; Creighton CJ; Deneen B; Miller CR; Picketts DJ; Kannan K; Huse JT
Nat Commun; 2018 Mar; 9(1):1057. PubMed ID: 29535300
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma.
Malgulwar PB; Danussi C; Dharmaiah S; Johnson W; Singh A; Rai K; Rao A; Huse JT
Neuro Oncol; 2024 Jan; 26(1):55-67. PubMed ID: 37625115
[TBL] [Abstract][Full Text] [Related]
3. ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma.
Babikir H; Wang L; Shamardani K; Catalan F; Sudhir S; Aghi MK; Raleigh DR; Phillips JJ; Diaz AA
Genome Biol; 2021 Nov; 22(1):311. PubMed ID: 34763709
[TBL] [Abstract][Full Text] [Related]
4. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.
Wang Y; Yang J; Wild AT; Wu WH; Shah R; Danussi C; Riggins GJ; Kannan K; Sulman EP; Chan TA; Huse JT
Nat Commun; 2019 Feb; 10(1):943. PubMed ID: 30808951
[TBL] [Abstract][Full Text] [Related]
5. Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.
Oppel F; Tao T; Shi H; Ross KN; Zimmerman MW; He S; Tong G; Aster JC; Look AT
PLoS Genet; 2019 Apr; 15(4):e1008039. PubMed ID: 30970016
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into the epigenetics of diffuse glioma.
Danussi C; Huse JT
Mol Cell Oncol; 2018; 5(5):e1472055. PubMed ID: 30263940
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.
Kannan K; Inagaki A; Silber J; Gorovets D; Zhang J; Kastenhuber ER; Heguy A; Petrini JH; Chan TA; Huse JT
Oncotarget; 2012 Oct; 3(10):1194-203. PubMed ID: 23104868
[TBL] [Abstract][Full Text] [Related]
8. Global changes in chromatin accessibility and transcription following ATRX inactivation in human cancer cells.
Liang J; Liu H; Li G; Qian J; Gao R; Zhou Y; Wang X
FEBS Lett; 2020 Jan; 594(1):67-78. PubMed ID: 31329278
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma.
Malgulwar PB; Danussi C; Dharmaiah S; Johnson WE; Rao A; Huse JT
bioRxiv; 2023 Jan; ():. PubMed ID: 36711727
[TBL] [Abstract][Full Text] [Related]
10. Mutant ATRX: uncovering a new therapeutic target for glioma.
Haase S; Garcia-Fabiani MB; Carney S; Altshuler D; Núñez FJ; Méndez FM; Núñez F; Lowenstein PR; Castro MG
Expert Opin Ther Targets; 2018 Jul; 22(7):599-613. PubMed ID: 29889582
[TBL] [Abstract][Full Text] [Related]
11. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
Brosnan-Cashman JA; Yuan M; Graham MK; Rizzo AJ; Myers KM; Davis C; Zhang R; Esopi DM; Raabe EH; Eberhart CG; Heaphy CM; Meeker AK
PLoS One; 2018; 13(9):e0204159. PubMed ID: 30226859
[TBL] [Abstract][Full Text] [Related]
12. [Application of ATRX in diagnosis and prognostic evaluation of glioma].
Li Z; Piao YS; Zhang LY; Wang LM; Wang DD; Fu YJ; Cai YN; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):690-694. PubMed ID: 29050070
[No Abstract] [Full Text] [Related]
13. ATRX, a guardian of chromatin.
Aguilera P; López-Contreras AJ
Trends Genet; 2023 Jun; 39(6):505-519. PubMed ID: 36894374
[TBL] [Abstract][Full Text] [Related]
14. ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.
Qin T; Mullan B; Ravindran R; Messinger D; Siada R; Cummings JR; Harris M; Muruganand A; Pyaram K; Miklja Z; Reiber M; Garcia T; Tran D; Danussi C; Brosnan-Cashman J; Pratt D; Zhao X; Rehemtulla A; Sartor MA; Venneti S; Meeker AK; Huse JT; Morgan MA; Lowenstein PR; Castro MG; Yadav VN; Koschmann C
Cell Rep; 2022 Jan; 38(2):110216. PubMed ID: 35021084
[TBL] [Abstract][Full Text] [Related]
15. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.
Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T
Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873
[No Abstract] [Full Text] [Related]
16. Functional Loss of
Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
[TBL] [Abstract][Full Text] [Related]
17. Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells.
Eid R; Demattei MV; Episkopou H; Augé-Gouillou C; Decottignies A; Grandin N; Charbonneau M
Mol Cell Biol; 2015 Aug; 35(16):2818-30. PubMed ID: 26055325
[TBL] [Abstract][Full Text] [Related]
18. Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2.
Modrek AS; Golub D; Khan T; Bready D; Prado J; Bowman C; Deng J; Zhang G; Rocha PP; Raviram R; Lazaris C; Stafford JM; LeRoy G; Kader M; Dhaliwal J; Bayin NS; Frenster JD; Serrano J; Chiriboga L; Baitalmal R; Nanjangud G; Chi AS; Golfinos JG; Wang J; Karajannis MA; Bonneau RA; Reinberg D; Tsirigos A; Zagzag D; Snuderl M; Skok JA; Neubert TA; Placantonakis DG
Cell Rep; 2017 Oct; 21(5):1267-1280. PubMed ID: 29091765
[TBL] [Abstract][Full Text] [Related]
19. Radiologic findings and the molecular expression profile of diffuse midline glioma H3 K27M mutant.
Seong M; Kim ST; Noh JH; Kim YK; Kim HJ
Acta Radiol; 2021 Oct; 62(10):1404-1411. PubMed ID: 33175579
[TBL] [Abstract][Full Text] [Related]
20. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.
Minasi S; Baldi C; Gianno F; Antonelli M; Buccoliero AM; Pietsch T; Massimino M; Buttarelli FR
Childs Nerv Syst; 2021 Mar; 37(3):809-818. PubMed ID: 33128602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]